Nelson H, Mullins N, Abell A
J Biol Chem. 2024; 301(2):108116.
PMID: 39710325
PMC: 11787431.
DOI: 10.1016/j.jbc.2024.108116.
Balboa E, Saud F, Parra-Ruiz C, De la Fuente M, Landskron G, Zanlungo S
Front Pharmacol. 2024; 15:1406784.
PMID: 38978979
PMC: 11228318.
DOI: 10.3389/fphar.2024.1406784.
Binh D, Cheng T, Tu S, Liao Y, Yang Y, Chen L
Am J Cancer Res. 2023; 13(11):5151-5173.
PMID: 38058811
PMC: 10695785.
Bi Y, Hu J, Zeng L, Chen G, Cai H, Cao H
J Cancer Res Clin Oncol. 2023; 149(20):17973-17986.
PMID: 37966613
PMC: 10725361.
DOI: 10.1007/s00432-023-05494-4.
Niimi A, Limsirichaikul S, Kano K, Mizutani Y, Takeuchi T, Sawangsri P
Cancers (Basel). 2023; 15(10).
PMID: 37345118
PMC: 10216351.
DOI: 10.3390/cancers15102781.
STARD3: A New Biomarker in HER2-Positive Breast Cancer.
Lodi M, Voilquin L, Alpy F, Moliere S, Reix N, Mathelin C
Cancers (Basel). 2023; 15(2).
PMID: 36672312
PMC: 9856516.
DOI: 10.3390/cancers15020362.
Expression and Function of StAR in Cancerous and Non-Cancerous Human and Mouse Breast Tissues: New Insights into Diagnosis and Treatment of Hormone-Sensitive Breast Cancer.
Manna P, Ramachandran S, Pradeepkiran J, Molehin D, Castro-Piedras I, Pruitt K
Int J Mol Sci. 2023; 24(1).
PMID: 36614200
PMC: 9820903.
DOI: 10.3390/ijms24010758.
LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.
Vanderheijden C, Vaessen T, Yakkioui Y, Riedl R, Temel Y, Hovinga K
J Neurooncol. 2022; 158(1):81-88.
PMID: 35507100
PMC: 9166821.
DOI: 10.1007/s11060-022-04012-9.
LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-1/Smad/Snail Pathway.
Xue Q, Jiang H, Wang J, Wei D
Can Respir J. 2021; 2021:5277409.
PMID: 34912481
PMC: 8668282.
DOI: 10.1155/2021/5277409.
Keratin 1 as a cell-surface receptor in cancer.
Ogunnigbagbe O, Bunick C, Kaur K
Biochim Biophys Acta Rev Cancer. 2021; 1877(1):188664.
PMID: 34890750
PMC: 8818032.
DOI: 10.1016/j.bbcan.2021.188664.
TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation.
Kolliopoulos C, Chatzopoulos A, Skandalis S, Heldin C, Heldin P
Cancers (Basel). 2021; 13(5).
PMID: 33804427
PMC: 7957764.
DOI: 10.3390/cancers13051021.
MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
Shen Y, Yang Y, Li Y
Thorac Cancer. 2020; 11(12):3473-3481.
PMID: 33074595
PMC: 7705923.
DOI: 10.1111/1759-7714.13678.
LIM and SH3 protein 1 localizes to the leading edge of protruding lamellipodia and regulates axon development.
Pollitt S, Myers K, Yoo J, Zheng J
Mol Biol Cell. 2020; 31(24):2718-2732.
PMID: 32997597
PMC: 7927181.
DOI: 10.1091/mbc.E20-06-0366.
The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer.
Tilley A, Howard C, Sridharan S, Subramaniyan B, Bearss N, Alkhalili S
Cancers (Basel). 2020; 12(9).
PMID: 32872485
PMC: 7564666.
DOI: 10.3390/cancers12092455.
Nonstructural NS5A Protein Regulates LIM and SH3 Domain Protein 1 to Promote Hepatitis C Virus Propagation.
Choi J, Kim J, Nguyen L, Nguyen H, Park E, Choi D
Mol Cells. 2020; 43(5):469-478.
PMID: 32344996
PMC: 7264479.
DOI: 10.14348/molcells.2020.0018.
Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer.
Peretti D, Kim S, Tufi R, Lev S
Front Cell Dev Biol. 2020; 7:371.
PMID: 32039198
PMC: 6989408.
DOI: 10.3389/fcell.2019.00371.
Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.
Lin C, Yang S, Huang Y, Lane H
Sci Rep. 2019; 9(1):18840.
PMID: 31827227
PMC: 6906281.
DOI: 10.1038/s41598-019-55414-1.
ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A, Dai H, Gong Y, Zhang C, Shu J, Luo Y
J Exp Clin Cancer Res. 2019; 38(1):347.
PMID: 31395079
PMC: 6686567.
DOI: 10.1186/s13046-019-1340-7.
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.
Chen K, Quan J, Yang J, Chen Z
Clin Transl Oncol. 2019; 22(4):576-584.
PMID: 31209793
DOI: 10.1007/s12094-019-02163-2.
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Manna P, Ahmed A, Yang S, Narasimhan M, Cohen-Tannoudji J, Slominski A
Cancers (Basel). 2019; 11(5).
PMID: 31060224
PMC: 6562549.
DOI: 10.3390/cancers11050623.